In this light, it is important to highlight that glucocorticoids (dexamethasone, methylprednisolone, and hydrocortisone), which act as suppressors of systemic inflammation, have been reported to ameliorate the outcome of COVID-19, especially in hospitalized patients who require supplemental oxygen (WHO ...